Approval · Notice of Compliance 12861 · 2011
FERAHEME: Notice of Compliance 12861
Issued December 8, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12861
- Date
- December 8, 2011
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Hematinic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FERAHEME | 02377217 | Cancelled Post Market |
Medicinal ingredients
- FERUMOXYTOL 30 MG per ML